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Abbreviations 
 
µg/mL Microgram per milliliter 
µL Micro liter 
µM Micro molar 
13C NMR Carbon Nuclear Magnetic Resonance 
1H NMR Proton Nuclear Magnetic Resonance 
calcd Calculated 
CD Circula Dichroism 
CDCl3 Deuterated chloroform 
CH2Cl2                   Dichloromethane 
CH3 Methyl 
CH3CN Acetonitrile 
CHCl3 Chloroform 
CO2 Carbondioxide 
COSY Correlation Spectroscopy 
DMEM Dulbecco’s Modified Eagle’s Medium 
DMSO Dimethylsulfoxide 
EtOAc Ethyl acetate 
g Gram 
H2O Water 
HCl Hydrochloric acid 
HeLa Human cervical cancer cell line 
HMBC Heteronuclear Multiple Bond Correlation 
HMQC Heteronuclear Multiple Quantum Correlation 
HPLC High Performance Liquid Chromatography  
HREIMS High Resolution Electron Impact Mass Spectrometry 
HRESIMS High Resolution Electron Spray Ionization Mass Spectrometry 
IC50 Concentration of inhibitory causing 50% reduction in activity 
relative to the control 
IR Infrared 
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KBr Potassium bromide 
J Coupling constant 
m/z Mass-to-charge ratio 
MeOH Methanol 
mg Milligram 
MHz Megahertz 
MIC Minimum inhibitory concentration  
min Minute 
mM Millimolar 
MPLC Medium Pressure Liquid Chromatography 
MS Mass Spectroscopy 
m Multiplicity 
nm  Nanometer 
NMR Nuclear Magnetic Resonance 
NOESY Nuclear Overhauser Effect Spectroscopy 
OH Hydroxy 
OCH3 Methoxy 
pTLC Preparative Thin Layer Chromatography 
PBS Phosphate buffered saline 
RP Reversed Phase 
TLC Thin Layer Chromatography 
TMS Tetramethylsilane 
UV Ultra Violet 
YP Yeast extract Peptone 
 
 
 
 
 
 
 3 
 
Chapter 1 Introduction 
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Melanin is a mixture of pigmented biopolymers synthesized by the basal layer 
of the epidermal melanocytes. The important role of melanin is to prevent skin damage 
by harmful ultraviolet (UV) radiation, stress from the different sources of environmental 
pollutants, toxic drugs, and chemicals. However, excessive synthesis of melanin in 
human body from overexposure to UV radiation causes hyperpigmentation and our skin 
becomes darker. Hyperpigmentation led to dermatological problems, which include age 
spots, melasma, melanoderma, lentigo, and freckles. On the other hand, decrease of 
the melanin synthesis led to hypopigmentation, such as vitiligo and albinism.1-6 
Therefore, melanin synthesis (melanogeneis) has an important role in skin pigmentation.  
Melanin is distinguished into two different types, eumelanin (dark brown/black 
insoluble pigments found in dark skin and dark hair) and pheomelanin (lighter 
red/yellow). Melanin is formed by melanogenesis through the complex enzymatic and 
biochemical-catalyzed reactions. Enzymatically, three key enzymes, tyrosinase (TYR), 
tyrosinase-related protein-1 (TRP-1), and tyrosinase-related protein-2 (TRP-2, also 
known as dopachrome tautomerase), regulate the melanogenesis. Tyrosinase catalyzes 
hydroxylation of tyrosine to form L-b-3,4-dihydroxyphenylalanine (L-DOPA) and 
oxidation of L-DOPA to produce DOPA quinone. TRP-2 converts DOPA chrome to 
5,6-dihydroxyindole-2-carboxylic acid (DHICA), and then TRP-1 catalyzes the 
oxidation of DHICA to form indole-5,6-dihydroxyindole-2-carboxylic acid (Figure 1.1). 
7-14 
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Figure 1.1 Biosynthesis of eumelanin and pheomelanin 
 
The expression of three melanogenic enzymes (TYR, TRP-1, and TRP-2) is 
stimulated through the intracellular pathways. The major pathway of melanogenesis is 
supposed to be the cAMP dependent pathway. UV exposure causes the production of 
alpha melanocyte-stimulating hormone (a-MSH). When a-MSH binds to its receptor, 
melanocortin receptor 1 (MC1R) located on the membrane of melanocytes activates 
cyclic adenosine monophosphate (cAMP) pathway. Protein kinase A (PKA) and other 
proteins were activated by cAMP. The cAMP response element binding protein (CREB) 
is phosphorylated by PKA and activates the gene expression of microphthalmia- 
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associated transcription factor (MITF) (Figure 1.2). 15-17 The activation of MITF leads 
to the expression of the melanogenesis-related enzymes, thus up-regulating 
melanogenesis. However, inhibition of the MITF activity results in down-regulation of 
the melanogenesis-related enzymes and thereby inhibites melanogenesis. Hence, MITF 
and the melanogenesis related enzymes are known as the target to regulate 
melanogenesis. Secondary metabolites derived from natural products have been shown 
to inhibit the process of melanogenesis with down regulation of cAMP pathway (Figure 
1.3). 
 
 
 
 
Figure 1.2 cAMP pathway of melanogenesis 
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Figure 1.3 Chemical structures of cAMP pathway melanogenesis inhibitiors 
 
Myanmar is located in South-East Asia bordered by India and Bangladesh, 
Thailand, Laos, and China (Figure 1.4). More than 40% of Myanmar is covered by 
mountains. Myanmar is characterized by three seasons, wet, cold, and dry. According to 
International Union for Conservation of Nature (IUCN), more than 18,000 species of 
plants have been recorded in Myanmar. Many of them have been used as traditional 
cosmetics or folk medicine. However, scientific evidence for using them is not fully 
reported.18 Furthermore, Myanmar is well known as a rich source of not only medicinal 
plants, but also marine sponges.  
Sponges are spineless animals that belong to phylum, Porifera, and considered 
as the most primitive multicellular animals existing for million years before. Marine 
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sponges have soft or hard bodies with many particles, and take nutrients such as organic 
particle and microorganism with filter feeding of see water.19–21 In the last decades, 
approximately 200 new compounds have been isolated from marine sponges for every 
year. Most of the compounds isolated from marine sponges exhibited antitumor, 
antiviral, anti-inflammatory, antimalarial, immunosuppressive, or antibiotic 
activities,22–35 and clinical trials were conducted for some of the compounds to develop 
new drugs, as exampled by salinosporamide A, bryostatin 1, tetrodotoxin (TTX), and 
anthramycin for cancer, Alzheimer, pain, and bacterial infections.36 However, to the best 
of our knowledge, none of the Myanmar marine sponges has been studied for their 
chemical constituents. These facts encouraged us to discover bioactive secondary 
metabolites from Myanmar natural resources (plants and sponges). 
 
 
Figure 1.4 The union of Myanmar 
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In order to find new candidates with significant anti-melanin deposition activity, 
five plants, Premna serratifolia (syn: P. integrifolia), Naringi crenulata, Hesperethusa 
crenulata, Gentiana kurroo, and Jatropha multifida, were collected in Myanmar. All 
these plants were extracted with CHCl3 and MeOH to obtain crude extracts. 
Anti-melanin deposition activity against a mouse melanoma cell line (B16-F10) 
supplied with a-melanocyte-stimulating hormone (a-MSH) and a potent cyclic 
nucleotide phosphodiesterase inhibitor, 3-isobutyl-1-methylxanthine (IBMX) to produce 
melanin revealed that the CHCl3 extracts of the Premna serratifolia wood and the 
Jatropha multifida stems showed moderate anti-melanin deposition activities with IC50 
values of 81.3 and 22.7 mg/mL, respectively, as compared with that of the positive 
control, arbutin (Figure 1.5). 
On the other hand, a 50% MeOH fraction obtained from a MeOH-acetone 
mixture (2:1) crude extract of a Clathria prolifera sponge also exhibited moderate 
anti-melanin deposition activity against B16-F10 with an IC50 value of 76.9 mg/mL, as 
compared to the positive control, arbutin (Figure 1.6). The cell viability was evaluated 
with the total protein contents by using Bio-rad Bradford assay. 
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Figure 1.5 Anti-melanin deposition activities of crude extracts (CHCl3 and MeOH) in a mouse melanoma cell line B16-F10 
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Figure 1.6 Anti-melanin deposition activities of crude extract of C. prolifera and each fraction of C. prolifera in a mouse melanoma cell 
line B16-F10 
 12 
 
Thus, this study aimed to isolate new compounds from two plants, the P. 
serratifolia wood and the J. multifida stems, and a marine sponge C. prolifera by 
focusing on anti-melanin deposition activity.  
Chapter 2 will discuss about the isolation and structure elucidation of new 
compounds from the P. serratifolia wood as well as the anti-melanin deposition 
activities of all isolated compounds from this plant. Chapter 3 will mainly discuss about 
the anti-melanin deposition activities of isolated compounds from the J. multifida stems. 
Finally, isolation and structure elucidation of new compounds from the marine sponge C. 
prolifera collected in Myanmar and their anti-melanin deposition activities will be 
discussed in Chapter 4. 
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Chapter 2  Constituents of the Premna serratifolia wood 
collected in Myanmar and their melanogenesis 
regulatory activities 
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2.1 Introduction 
P. serratifolia (syn: P. integrifolia) (Verbenaceae) (Figure 2.1) is widely 
distributed in near western sea coast from South Asia to South East Asia, which include 
India, Malaysia, Vietnam, Cambodia, and Sri Lanka. A part of this plant such as leaves 
and roots are used for treatment of various diseases, including indigestion, dysuria, 
dysentery, stomachache, fever, diabetes, inflammation, headache, and bronchitis, as well 
as kidney and liver problems.37-40 The leaves of this plant have been reported for 
anti-coagulant, anti-inflammatory, anti-microbial, cytotoxicity, antioxidant, and 
gastroprotective activities. In addition, the roots of P. serratifolia exhibited cytotoxicity, 
antioxidant, and anti-microbial activities. Furthermore, the flowers, bark, and wood of 
this plant showed anti-inflammatory and antioxidant activities.41-50 P. serratifolia is 
usually called as “Taung-tangyi” in Myamar, and people in Tanintharyi region located in 
the southern part of Myanmar have utilized the bark and wood of P. serratifolia as 
ingredient to make the traditional cosmetics “Thanaka” for many centuries. Thanaka is 
applied in the form of paste onto face, arms, and legs to make smooth and clear skin as 
well as to prevent wrinkles, skin aging, excessive facial oil, pimples, blackheads, and 
whiteheads.51 Several phytochemical studies reported the isolation of alkaloids, iridoid 
glycosides, steroids, acteoside, diterpenes, and polyisoprenoid as well as pharmaceutical 
properties of those compounds such as anti-coagulant, anti-arthritic, anti-hyperglycemic, 
cytotoxicity, antioxidant, antinociceptive, gastroprotective, anti-inflammatory, and 
anti-microbial activities.37, 52-54 However, its cosmetic properties have not yet been 
investigated.  
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2.2 Extraction and isolation  
The dried powder of the P. serratifolia wood (4.8 kg) was sonicated in CHCl3 
(8 L, 90 min, ´4) at room temperature and after removing the solvent under reduced 
pressure, the CHCl3 extract (31.5 g) was obtained. The CHCl3 extract (31.5 g) was 
applied to silica gel column chromatography eluted with n-hexane-EtOAc (10:1, 8:2, 
7:3, 5:5, 3:7, 2:8, 0:10, v/v) as a gradient solvent system to give ten fractions (Fr. 1-10). 
These fractions were further subjected to series of chromatographic separation, which 
led to isolation of eleven compounds including four new lignoids, premnan A (1, 1.7 
mg), premnan B (2, 1.6 mg), taungtangyiol C (3, 3.0 mg),55 and 
7,9-dihydroxydolichanthin B (4, 8.1 mg),56 together with premnan C (5, 2.1 mg)55 
assumed to be an artifact, one natural new lignoid (3R,4S)-4-(1,3-benzodioxol- 
5-ylcarbonyl)-3-[(R)-1-(1,3-benzodioxol-5-yl)-1-hydroxymethyl]tetrahydro-2-furanone 
(6, 1.6 mg),57 and five known compounds (-)-aptosimon (7, 3.4 mg),  
(-)-diasesamin-di-g-lactone (8, 17.1 mg),58 and (+)-epi-sesaminone (9, 4.0 mg),59 
oleanonic acid (10, 4.2 mg),60 and (2a, 3a)-dihydroxyolean-12-en-28-oic acid (11, 3.3 
mg)61] (Figures 2.2, 2.3 and 2.4). All new compounds were elucidated based on 1D and 
2D NMR, IR spectroscopy, and HRESIMS. The absolute configurations of 1-3 and 5 
were also determined by optical rotation and circular dichroism (CD) data analysis, and 
the known compounds 6-11 were identified by comparisons of their spectroscopic data 
and the reported literatures.  
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Figure 2.1. Premna serratifolia wood 
 
 
 
 
Figure 2.2 Extraction and isolation of compounds from CHCl3 extract of P. serratifolia 
wood 
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Figure 2.3 Structures of new compounds isolated from CHCl3 extract of P. serratifolia 
wood  
 
 
Figure 2.4 Structures of known compounds isolated from CHCl3 extract of P. 
serratifolia wood  
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2.3 Structure elucidation of new compounds  
2.3.1 Premnan A (1) 
Compound 1 was obtained as a pale yellowish amorphous solid with positive 
optical rotation ([a]D25 +83.2° (c 0.1, MeOH)). The HRESIMS of 1 indicated molecular 
ion clusters [M+Na]+ (m/z 375.0869) and its molecular formula was deduced as 
C20H16O6 in conjugation with NMR data. The IR spectrum showed characteristic 
absorption bands corresponding to the hydroxy functional group (3463 cm−1) and the 
aromatic ring (1640, 1592, and 1485 cm−1). The UV spectrum of 1 showed absorption 
maxima at 247 and 360 nm. The 1H NMR spectrum (Figure 2.5, Table 2.1) showed 
signals of an aldehyde group [dH 9.54, (s, H-2a)], three aromatic/olefinic methines [dH 
7.27 (s, H-1), 6.86 (s, H-8), 6.68 (s, H-5)], a 1,3,4-trisubstituted phenyl group [dH 6.42 
(d, J = 1.8 Hz, H-2¢), 6.63 (d, J = 8.1 Hz, H-5¢), 6.44 (dd, J = 1.8, 8.1 Hz, H-6¢)], two 
dioxymethylenes [dH 5.87 (d, J = 1.5 Hz, H-7¢a), 5.86 (d, J = 1.5 Hz, H-7¢b), 6.01 (d, J 
= 1.5 Hz, H-11a), 6.00 (d, J = 1.5 Hz, H-11b)], an oxymethylene [dH 3.63 (dd, J = 5.7, 
10.7 Hz, H-3aa), 3.40 (dd, J = 8.6, 10.7 Hz, H-3ab)], and two methines [dH 4.28, (s, 
H-4), 3.20 (m, H-3)]. The 13C NMR (Figure 2.6, Table 2.1) and HMQC data revealed 
the presence of 20 carbon signals, including an aldehyde carbonyl [dC 193.1 (C-2a)], 
four oxygenated aromatic quaternary carbons [(dC 150.6 (C-6), 147.8 (C-3¢), 147.4 
(C-7), 146.3 (C-4¢)], an olefinic methine [dC 146.8 (C-1)], four aromatic/olefinic 
non-protonated carbons [(dC 137.7 (C-1¢), 135.3 (C-2), 134.4 (C-10), 125.1 (C-9)], five 
aromatic methines [(dC 120.5 (C-6¢), 110.9 (C-5), 109.0 (C-8), 108.3 (C-5¢), 108.0 
(C-2¢)], two dioxymethylenes [dC 101.9 (C-11), 101.1 (C-7¢)], an oxymethylene [dC 63.6 
(C-3a)], and two sp3 methines [dC 44.5 (C-4), 42.8 (C-3)]. According to the HMBC 
correlations from H-1 to C-2/C-3/C-8/C-10, from H2-3a to C-2/C-4, from H-4 to 
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C-2/C-5/C-9/C-10, from H-5 to C-6/C-7/C-9, and from H-8 to C-6/C-7/C-10 (Figure 
2.7a), a 3-hydroxymethyl-3,4-dihydronapthalene ring (numbering according to 1) was 
established in the structure of 1. 1H-1H COSY correlations of H-3/H-4 and H-3/H-3a 
allowed us to attach the hydroxymethyl group at C-3 (Figure 2.7a). Furthermore, the 
downfield shifts of the C-1 methine proton (δH 7.27) and the carbon (δC 146.8), and the 
HMBC correlations from H-1 to C-2a and from H-2a to C-2/C-3 suggested that the 
aldehyde group was attached to C-2. The HMBC correlations from H-1 to 
C-2a/C-3/C-8/C-10, from H-4 to C-2/C-5/C-9/C-10, from H-5 to C-6/C-7/C-9, and 
from H-8 to C-6/C-7/C-10 suggested the presence of a 1,2-dihydronaphthalene in 1. 
Based on the observation of HMBC correlation from H2-11 to the downfield-shifted 
aromatic quaternary carbons at C-6 and C-7, a methylenedioxy group was directly 
attached to the 1,2-dihydronaphthalene at C-6 and C-7. In contrast, the COSY 
correlation of H-5¢/H-6¢ and the HMBC correlations from H-2¢/H-6¢ to C-4¢, from H-5¢ 
to C-1¢/C-3¢, and from H2-7¢ to C-3¢/C-4¢ revealed the presence of the 
methylenedioxyphenyl group as a partial structure of 1. The HMBC correlations from 
H-4 to C-1¢/C-2¢/C-6¢ confirmed the attachment of the methylenedioxyphenyl group at 
C-4. Thus, compound 1 was determined to be a phenylnaphthalene-type lignan 
containing two piperonyl rings as the partial structure, and the planar structure of 1 was 
elucidated as shown in Figure 2.3. 
 The planner structure of 1 was close resemblance to vitexdoin A,62 containing 
the 3,4-dihydroxybenzene and 4-hydroxy-3-methoxybenzene rings, instead of the 
piperonyl rings of 1. The singlet methine signal at H-4 in 1, associated with a small 
coupling constant close to zero due to the dihedral angle of ca. 90° between H-3 and 
H-4, and the cross peak of H-4/H2-3a in the NOESY spectrum suggested the trans 
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relationship between H-3 and H-4 (Figure 2.7b), as observed in the relationships of the 
corresponding protons in vitexdoin A.62,63 However, comparisons of ECD curves (242 
and 348 nm were positive, while 213, 260, and 316 nm were negative for 1; 242 and 
348 nm were negative, while 213, 260, and 316 nm were positive for vitexdoin A) 
(Figure 2.8) and optical rotation ([a]D25 +83.2° for 1; [a]D15 -156.0° for vitexdoin 
A)62-64 between 1 and vitexdoin A with the 3R, 4S absolute configuration revealed that 
they are totally opposite. Thus, the absolute configurations of 1 were determined as 3S 
and 4R, and 1 was named premnan A. 
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Figure 2.5 1H NMR spectrum (500 MHz) of 1 in CDCl3 
 
 
 
Figure 2.6 13C NMR spectrum (125 MHz) of 1 in CDCl3 
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Figure 2.7 1H-1H COSY correlations (bold lines) and key HMBC correlations (arrows) 
(a) and key NOESY correlations (dashed arrows) of 1 (b) 
 
 
 
 
 
Figure 2.8 Experimental ECD spectra of 1 and vitexdoin A 
 
 
 23 
 
Table 2.1 
1H (500 MHz) and 13C NMR (125 MHz) spectroscopic data for 1 in CDCl3 (d in ppm and 
J values in (Hz) in parentheses) 
 
position 
1 
dH  dC 
1 7.27, s 146.8, CH 
2  135.3, C 
2a 9.54, s 193.1, CH 
3 3.20, m 42.8, CH 
3aa 3.63, dd (5.7, 10.7) 63.6, CH2 
3ab 3.40, dd (8.6, 10.7)  
4 4.28, brs 44.5, CH 
5 6.68, s 110.9, CH 
6  150.6, C 
7  147.4, C 
8 6.86, s 109.0, CH 
9  125.1, C 
10  134.4, C 
11a 6.01, d (1.5) 101.9, CH2 
11b 6.00, d (1.5)  
12   
1¢  137.7, C 
2¢ 6.42, d (1.8) 108.0, CH 
3¢  147.8, C 
4¢  146.3, C 
5¢ 6.63, d (8.1) 108.3, CH 
6¢ 6.44, d (1.8, 8.1) 120.5, CH 
7¢a 5.87, d (1.5) 101.1, CH2 
7¢b 5.86, d (1.5)  
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2.3.2 Premnan B (2) 
Compound 2 was isolated as a white amorphous solid. The optical rotation of 2 
exhibited [a]D25 +1.6° (c 0.1, MeOH). The HRESIMS analysis of 2 showed molecular 
ion peak at m/z 409.0868 [M+Na]+ corresponding to molecular formula C20H18O8. The 
IR spectrum of 2 showed absorption bands of the hydroxy group at 3470 cm−1 and the 
aromatic ring at 1638 and 1498 cm−1, respectively. The UV spectrum showed absorption 
maxima at 245 and 288 nm. The 1H NMR spectrum of 2 (Figure 2.9, Table 2.2) revealed 
resonances characteristic of a 1,3,4-trisubstituted phenyl group [dH 7.03 (d, J = 1.3 Hz, 
H-2²), 6.86 (dd, J = 1.3, 7.9 Hz, H-6²), 6.77 (d, J = 7.9 Hz, H-5²)], three aromatic 
methines [dH 6.92 (brs, H-2¢), 6.83 (m each, H-5¢, H-6¢)], two dioxymethylenes [dH 5.98 
(s, H2-7²), 5.96 (s, H2-7¢)], three oxymethines [dH 5.34 (s, H-8), 4.97 (s, H-2), 4.88 (d, J 
= 7.4 Hz, H-6)], an oxymethylene [dH 4.41 (dd, J = 6.2, 9.1 Hz, H-4a), 4.08 (dd, J = 2.6, 
9.1 Hz, H-4b)], an aliphatic methine [dH 2.91 (m, H-5)], and a hydroxy group [dH 2.30 
(s, 1-OH)]. The 13C-NMR spectrum (Figure 2.10, Table 2.2) showed four oxygenated 
aromatic quaternary carbons [(dC 148.3 (C-3²), 148.2 (C-3¢), 148.1 (C-4¢), 147.6 (C-4²)], 
two aromatic non-protonated carbons [(dC 135.4 (C-1²), 129.6 (C-1¢)], six aromatic 
methines [(dC 120.4 (C-6¢), 120.0 (C-6²), 108.5 (C-5¢), 108.2 (C-5²), 107.8 (C-2¢), 107.0 
(C-2²)], two dioxymethylenes [dC 101.4 (C-7²), 101.3 (C-7¢)], four sp3 oxymethines [dC 
97.6 (C-8), 85.8 (C-2), 85.3 (C-6)], an oxygenated sp3 quaternary carbon [dC 90.5 (C-1)], 
an sp3 oxymethylene [dC 70.9 (C-4)], and an sp3 methine [dC 58.6 (C-5)]. The above 
NMR data of 2 and the HMBC experiment (Figure 2.11a) revealed a close structural 
resemblance to (+)-paulownin, the furoruran lignan isolated from Cycas vespertilio.65 
Significant difference was the presence of a hydroxy group at C-8 in 2. The HMBC 
correlations from 1-OH/H-2/H-6 to C-8, as well as downfield-shifted sp3 methine signal 
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at C-8 in 2, instead of the sp3 methylene signal at this position in paulownin also 
supported this assignment. A cis relationship of H-5 and the hydroxyl group at C-1, as 
well as the a-orientations of H-5, the two methylenedioxyphenyl groups at C-2 and C-6, 
and the C-1 and C-8 hydroxyl groups were revealed by the NOESY correlations of 
H-2/H-6, H-2/H-8, H-4a/H-6, 1-OH/H-5, and 1-OH/H-6¢ (Figure 2.11b). Furthermore, 
the absolute configurations of 2 were determined as 1R, 2R, 5R, 6S, and 8R from the 
ECD spectra analysis (Figure 2.12) and 2 was named premnan B. 
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Figure 2.9 1H NMR spectrum (500 MHz) of 2 in CDCl3 
 
 
 
 
Figure 2.10 13C NMR spectrum (125 MHz) of 2 in CDCl3 
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Figure 2.11 1H-1H COSY correlations (bold lines) and key HMBC correlations (arrows) 
(a) and key NOESY correlations (dashed arrows) of 2 (b) 
 
 
 
 
 
Figure 2.12 ECD spectra of 2 
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Table 2.2 
1H (600 MHz) and 13C NMR (150 MHz) spectroscopic data for 2 in CDCl3 (d in ppm and 
J values in (Hz) in parentheses) 
 
position 
2 
dH  dC 
1  90.5, C 
2 4.97, s, 1H 85.8, CH 
4a 4.41, dd (6.2, 9.1),  70.9, CH2 
4b 4.08, dd (2.6, 9.1)  
5 2.91, m 58.6, CH 
6 4.88, d (7.4) 85.3, CH 
8 5.34, s 97.6, CH 
1¢  129.6, C 
2¢ 6.92, brs 107.8, CH 
3¢  148.2, C 
4¢  148.1, C 
5¢ 6.83c, m 108.5, CH 
6¢ 6.83c, m 120.4, CH 
7¢ 5.96, 2H, s 101.3, CH2 
1²  135.4, C 
2² 7.03, d (1.3) 107.0, CH 
3²  148.3, C 
4²  147.6, C 
5² 6.77, d (7.9) 108.2, CH 
6² 6.86, dd (1.3, 7.9) 120.0, CH 
7² 5.98, 2H, s 101.4, CH2 
1-OH 2.30, s  
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2.3.3 Taungtangyiol C (3) 
Compound 3 was found as a white amorphous solid with a negative optical 
rotation ([a]D25 -55.5°(c 0.1, MeOH)). Its molecular formula was elucidated as 
C20H20O7 from molecular ion peak at m/z 395.1101 [M+Na]+ in the HRESIMS (calcd. 
for C20H20O7Na: 395.1101) and NMR data. The IR spectrum of 3 showed a 
characteristic absorption band of the hydroxy group at 3436 cm-1. The UV spectrum 
showed absorption maxima at 247 and 285 nm. The 1H and 13C NMR spectra (Figures 
2.13 and 2.14, Table 2.3), in combination with the HMQC spectroscopic data of 3 
recorded in CDCl3, were quite similar to those of taungtangyiol A,41 previously reported 
by our group recorded in CDCl3 (see experimental section). The significant difference 
between 3 and taungtangyiol A was the absence of the hydroxy group at C-5 in 3. This 
assignment was supported by the COSY correlations of H-1 (dH 2.56)/H-2 (dH 4.52), 
H-1/H-5 (dH 2.82), H-1/H2-7 (dH 4.01, 3.74), H-5/H2-4 (dH 3.72, 3.39), and H-5/H-6 (dH 
4.77) and the HMBC correlations of H2-7 to C-5 (Figure 2.15a). The relative 
configuration of the tetrahydrofuran ring moiety of 3 (C-1, C-2, and C-5) was 
determined by a NOESY experiment (Figure 2.15b). The cross peaks of H-4b (dH 
3.39)/H-6, H-4b/H-7a (dH 4.01), H-6/H-7a, H-2/H-7b (dH 3.74), and H-1/H-2² in the 
NOESY spectrum suggested b-orientations of H-2, C-6, and C-7, and α-orientations of 
H-5 and the methylenedioxyphenyl group at C-2. Based on the observations of the 
NOESY correlations of H-2¢ (dH 6.88)/H2-4 and H-4b/H-6 as well as comparison with 
the experimental ECD spectra and calculated ECD spectra (Figure 2.16), the absolute 
configurations of 3 were determined 1R, 2S, 5R, and 6S and 3 was named taungtangyiol 
C.  
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Figure 2.13 1H NMR spectrum (500 MHz) of 3 in CDCl3 
 
 
 
 
Figure 2.14 13C NMR spectrum (125 MHz) of 3 in CDCl3 
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Figure 2.15  1H-1H COSY correlations (bold lines) and key HMBC correlations 
(arrows) (a) and key NOESY correlations (dashed arrows) of 3 (b) 
 
 
 
 
 
 
Figure 2.16 Experimental and calculated ECD spectra of 3 
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Table 2.3 
1H (500 MHz) and 13C NMR (125 MHz) spectroscopic data for 3 in CDCl3 (d in ppm and 
J values in (Hz) in parentheses) 
 
position 
3 
dH  dC 
1 2.56, m 52.5, CH 
2 4.52, d (7.1) 83.2, CH 
4a 3.72, dd (7.4, 9.3) 70.5, CH2 
4b 3.39, dd (5.9, 7.4)  
5 2.82, m 48.9, CH 
6 4.77, d (10.0) 73.6, CH 
7a 4.01, dd (9.8, 11.3) 61.0, CH2 
7b 3.74, m  
1¢  136.6, C 
2¢ 6.88, d (1.5) 106.8, CH 
3¢  148.0, C 
4¢  147.8, C 
5¢ 6.75 a, m 108.4, CH 
6¢ 6.78 a, m 120.4, CH 
7¢ 5.98, 2H, s 101.4, CH2 
1²  136.0, C 
2² 6.81, brs 106.5, CH 
3²  148.3, C 
4²  147.3, C 
5² 6.78 a, m 108.2, CH 
6² 6.75 a, m 119.5, CH 
7² 5.95, 2H, s 101.2, CH2 
a Overlapping resonances assigned by HMQC spectrum. 
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2.3.4 7,9-Dihydroxydolichanthin B (4) 
Compound 4 was purified as a white amorphous solid, and displayed a 
molecular formula of C20H20O8 as deduced from the molecular ion adduct peak at m/z 
411.1049 [M+Na]+ (calcd. for C20H20O8Na: 411.1050) in the HRESIMS. The IR 
spectrum indicated the absorbance bands at 3405 cm-1 for hydroxyl group and 1646, 
1613 and 1490 cm-1 for aromatic rings. The UV spectrum showed absorption maxima at 
245 and 288 nm. The 1H NMR spectrum of 4 (Figure 2.17, Table 2.4) showed the 
resonances of two sets of 1,3,4-trisubstituted phenyl groups [dH 6.84 (d, J = 1.5 Hz, 1H, 
H-2²), 6.83 (brs, 1H, H-2¢), 6.82 (d, J = 8.0 Hz, 1H, H-5¢), 6.81 (d, J = 8.0 Hz, 1H, 
H-5²), 6.77 (dd, J = 1.5, 8.0 Hz, 1H, H-6¢), 6.74 (dd, J = 1.5, 8.0 Hz, 1H, H-6²)], two 
methylene dioxy groups [dH 5.99 (d, J = 1.0 Hz, 2H, H-7²), 5.98 (d, J = 1.0 Hz, 2H, 
H-7¢)], a dioxymethine [dH 4.89 (dd, J = 1.5, 5.5 Hz, 1H, H-2)], two oxygenated 
methines [dH 4.44 (dd, J = 3.2, 8.3 Hz, 1H, H-6), 4.33 (dd, J = 3.2, 8.6 Hz, 1H, H-7)], an 
oxygenated methylene [dH 3.53 (t, J = 8.6 Hz, 1H, H-4a), 3.39 (t, J = 8.3 Hz, 1H, H-4b)], 
two methine protons [dH 2.41 (m, 1H, H-5), 2.25 (ddd, J = 1.5, 5.4, 8.6 Hz, 1H, H-1)], 
and three hydroxy groups [dH 6.01 (d, J = 3.2 Hz, HO-6), 5.85 (d, J = 5.5 Hz, HO-2), 
5.84 (d, J = 3.2 Hz, HO-7)]. The 13C NMR (Figure 2.18, Table 2.4) and HMQC spectra 
confirmed the presence of six sp2 quaternary carbons [dC 147.1 (C-3²), 147.0 
(C-3¢/C-4²), 146.2 (C-4¢), 138.3 (C-1¢), 138.1 (C-1²)], six sp2 methine carbons [dC 120.4 
(C-6²), 119.6 (C-6¢), 107.7 (C-5²), 107.6 (C-2²), 107.2 (C-5¢), 106.6 (C-2¢)], two 
methylenedioxy carbons [dC 100.8 (C-7¢/C-7²)], one sp3 dioxymethine carbon [dC 100.4 
(C-2)], two sp3 oxymethine carbons [dC 74.3 (C-6), 73.9 (C-7)], an oxymethylene 
carbon [dC 68.2 (C-4)], and two sp3 methine carbons [dC 58.2 (C-1), 50.1 (C-5)]. The 1H 
NMR and 13C NMR spectroscopic data of 4 were quite similar to those of dolichanthin 
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B isolated from Wikstroemia dolichantha,66 except for the presence of a hydroxy group 
at C-2 instead of the methoxy group in dolichanthin B and an additional hydroxy group 
at C-7 in 4. This was also confirmed by deshielded C-1 (dC 58.2) and C-7 (dC 73.9) in 4, 
as compared with those of dolichanthin B (δC 49.8 and 38.9), respectively, as well as the 
COSY correlations of HO-2/H-2 and HO-7/H-7 and the HMBC correlations from HO-2 
to C-1, from H2-4 to C-2, from H-2 to C-1/C-5, from HO-7 to C-1/C-7/ C-1², from H-7 
to C-2/C-2²/C-6², and from H-6²/C-7 (Figure 2.19a). Furthermore, the NOESY 
correlations of H-1 with H-4a/H-6, of H-4a with H-6, of H-2 with H-5/H-7, and of H-5 
with H-7 indicated that 4 adopts the same relative configurations at H-1, H-2, H-5, C-6, 
and C-7 with those of corresponding H-8, H-9, H-8¢, C-7 and C-7¢ in dolichanthin B.66 
Based on these observations, H-1, the hydroxy group at C-2, and C-6 were assumed to 
be b-orientations, while H-2, H-5, and C-7 were assigned to be a-orientations. The large 
J5,6 values of 8.3 Hz and J1,7 values of 8.6 Hz, as observed at H-8¢ and H-7¢ in 
dolichanthin A (7.7 Hz) with a anti configuration,66 also supported each relationship to 
be the anti-configuration in 4, respectively. In addition, the NOESY spectrum (Figure 
2.19b) showed the correlations of H-4a/H-2¢, HO-6/H-1, HO-6/H-5, HO-7/H-1, 
HO-7/H-5, and H-2/H-2² suggested the hydroxy groups at C-6 and C-7 faced each other. 
Considering the NOESY correlations observed in 4 comprehensively, the relative 
structure of 4 was assigned as shown in Figure 2.19b. Hence, compound 4 was deduced 
to be a new dolichanthin B analog and was named 7,9-dihydroxydolichanthin B 
(numbering according to dolichanthin B). 
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Figure 2.17 1H NMR spectrum (500 MHz) of 4 in CDCl3 
 
 
 
 
Figure 2.18 13C NMR spectrum (125 MHz) of 4 in CDCl3 
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Figure 2.19 1H-1H COSY correlations (bold lines) and key HMBC correlations (arrows) 
(a) and key NOESY correlations (dashed arrows) of 4 (b) 
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Table 2.4 1H (500 MHz) and 13C (125 MHz) NMR data of 4 in DMSO-d6 (d in ppm 
and J values in (Hz) in parentheses) 
 
position 
4 
dH  dC 
1 2.25, ddd (1.5, 5.4, 8.6) 58.2, CH 
2 4.89, dd (1.5, 5.5) 100.4, CH 
4a 3.53, t (8.6) 68.2, CH2 
4b 3.39, t (8.3)  
5 2.41, m 50.1, CH 
6 4.44, dd (3.2, 8.3) 74.3, CH 
7 4.33, dd (3.2, 8.6) 73.9, CH 
1¢  138.3, C 
2¢ 6.83, brs 106.6, CH 
3¢  147.0 a, C 
4¢  146.2, C 
5¢ 6.82, d (8.0) 107.2, CH 
6¢ 6.77, dd (1.5, 8.0) 119.6, CH 
7¢ 5.98, d (1.0) 100.8 a, CH2 
1²  138.1, C 
2² 6.84, d (1.5) 107.6, CH 
3²  147.1, C 
4²  147.0 a, C 
5² 6.81, d (8.0) 107.7, CH 
6² 6.74, dd (1.5, 8.0) 120.4, CH 
7¢¢ 5.99, d (1.0) 100.8 a, CH2 
HO-2 5.85, d (5.5)  
HO-6 6.01, d (3.2)  
HO-7 5.84, d (3.2)  
a Overlapping resonances within the same column. 
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2.3.5 Premnan C (5) 
Compound 5 was obtained as a white amorphous solid with a positive optical 
rotation ([a]D25 +4.7° (c 0.1, MeOH)). HRESIMS suggested its molecular formula of 
C23H24O8 based on m/z 451.1368 [M+Na]+ (calcd. for C23H24O8Na: 451.1363), 
accounting for 12 indices of hydrogen deficiency. Absorption bands of the hydroxy 
group (3458 cm-1) and the aromatic ring (1547 and 1465 cm-1) were observed in the IR 
spectrum. The UV spectrum showed absorption maxima at 245 and 285 nm. The 
assignment of all protons and carbons of 5 was confirmed by 1D and 2D NMR 
spectroscopic data. The 1H and 13C NMR spectroscopic data recorded in CDCl3 (Figures 
2.20 and 2.21, Table 2.5) and the observation of the cross peaks in the HMBC spectra 
(Figure 2.22a) of 5 showed a close structural resemblance to taungtangyiol A.41 
However, the HMBC correlations from the two methyl groups at H3-11 (dH 1.44)/H3-12 
(dH 1.40) to C-8 (dC 102.0) indicated the presence of a 1,1-dimethylmethylenedioxy 
group in 5. Taking the indices of hydrogen deficiency into account, one more ring 
system should be included in the structure of 5 to fulfill the remaining degree of 
unsaturation. Thus, the presence of a 8,8-dimethyl-7,9-dioxepane ring (numbering 
according to 5) was supported by the HMBC correlations from H-6 (dH 4.92)/H2-10 (dH 
3.99, 3.47)/H3-11/H3-12 to C-8. The NOESY correlation (Figure 2.22b) between the 
5-OH (dH 2.85) and H-1 (dH 2.04) suggested that H-1 and the hydroxy group at C-5 
existed in a cis relationship, while the NOESY correlation of H-2/H-10b (dH 3.47) and 
the lack of NOESY correlation between 5-OH and H-2 (dH 5.04) indicated that H-1 and 
H-2 was trans relationship. Furthermore, the trans relationship between 5-OH and H-6, 
as well as H-2 and H-6 adopted b-orientations as verified from the NOESY correlations 
of 5-OH (dH 2.85)/H-2¢ (dH 7.00) and H-6 (dH 4.92)/H-6¢ (dH 6.86), and the lack of a 
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correlation between 5-OH/H-6. The absolute configurations of 5 were defined 1R, 2S, 
5S, and 6R by comparing the experimental ECD spectra with calculated ECD spectra 
and 5 was named premnan C. However, the existence of 5 in the CHCl3 extract was not 
proved by LC-HRESIMS analysis, suggesting that 5 may be an artifact produced during 
the purification process. 
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Figure 2.20 1H NMR spectrum (500 MHz) of 5 in CDCl3 
 
 
 
 
 
Figure 2.21 13C NMR spectrum (125 MHz) of 5 in CDCl3 
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Figure 2.22 1H-1H COSY correlations (bold lines) and key HMBC correlations (arrows) 
(a) and key NOESY correlations (dashed arrows) of 5 (b) 
 
 
 
 
 
Figure 2.23 Experimental and calculated ECD spectra of 5 
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Table 2.5 
1H (500 MHz) and 13C NMR (125 MHz) spectroscopic data for 5 in CDCl3 (d in ppm and 
J values in (Hz) in parentheses) 
 
position 
5 
dH  dC 
1 2.04, m 58.7, CH 
2 5.04, d (10.8) 81.2, CH 
4 3.79, 2H, s 72.8, CH2 
5  81.9, C 
6 4.92, s 73.4, CH2 
8  102.0, C 
10a 3.99, dd (2.3, 13.7)  
10b 3.47, dd (2.0, 13.7) 55.7, CH2 
11 1.44, 3H, s 24.3, CH3 
12 1.40, 3H, s 25.0, CH3 
1¢  131.4, C 
2¢ 7.00, d (1.7) 109.0, CH 
3¢  147.4, C 
4¢  147.8, C 
5¢ 6.78, d (8.0) 108.3, CH 
6¢ 6.86, dd (1.7, 8.0) 122.0, CH 
7¢ 5.97, 2H, d (1.5) 101.2, CH2 
1²  135.7, C 
2² 6.92, d (1.7) 106.6, CH 
3²  148.2, C 
4²  147.5, C 
5² 6.77, d (8.0) 107.9, CH 
6² 6.85, dd (1.7, 8.0) 120.1, CH 
7² 5.96, 2H, d (1.5) 101.2, CH2 
5-OH 2.85, s  
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2.4 Melanogenesis regulatory activity of isolated compounds in a mouse melanoma 
cell line (B16-F10) 
All the isolated compounds (1-11) were evaluated their anti-melanin 
deposition activities against a mouse melanoma cell line (B16-F10) at the concentration 
of 10, 50, and 100 mM. The cell viability was evaluated with the total protein contents 
by using Bio-rad Bradford assay. The positive control, arbutin, showed an IC50 value of 
698 mM (Figure 2.24). Among these compounds, 7,9-dihydroxydolichanthin B (4) and 
(2a,3a)-olean-12-en-28-oic acid (11) showed anti-melanin deposition activities with 
IC50 values of 18.4 and 11.2 mM, respectively, without any cytotoxicity. Oleanonic acid 
(10) showed dose-dependent of anti-melanin deposition activities with IC50 values of 
17.7 mM (Figures 2.24 and 2.25).56 However, at concentration above 50 mM, 10 showed 
slight cytotoxicity against B16-F10 cell line. It is in agreement with previous report on 
cytotoxic activity of oleanonic acid against B16-BL6 cell line.67 On the other hand, 
compounds 1-3, 5, and 7 showed melanogenesis enhancing activities. Compounds 1 
and 5 increased melanin production by 31% and 50% at a 50 mM concentration, 
respectively, while 1 and 5 showed slight cytotoxicity at the concentration of 100 mM, 
which would account for the reduction of the melanin production. Compounds 2, 3, and 
7 exhibited dose-dependent enhancement of melanin production by 67%, 30%, and 45%, 
respectively, at the concentration of 100 mM as compared to the cells treated only with 
IBMX and a-MSH (Figure 2.24).55 
 
 
 44 
 
 
Figure 2.24 Melanogenesis regulatory activities of 1-11 against a-MSH and 
IBMX-induced melanogenesis, as well as protein contents in B16-F10 cell line. Cells 
were seeded on a 24-well plate at 5.0 ´ 104 cells/well and cultured in 500 mL of medium 
(DMEM at 37 °C, under a 5% CO2 and 95% air atmosphere). After culture of 24 h, 500 
mL of medium containing different doses of the tested samples (final conc. 10, 50, and 
100 mM), a-MSH (final conc. 0.25 mM), and IBMX (final conc. 100 mM) were added to 
each well. After a 48 h incubation, 500 mL of the medium was discarded, and 500 mL of 
medium containing different doses of the tested samples (final conc. 10, 50, and 100 
mM), a-MSH (final conc. 0.25 mM), and IBMX (final conc. 100 mM) were added to 
each well and the cells were further incubated for 48 h. The cells were then lysed by 
incubation in 1 M NaOH (150 mL) at 95 °C for 15 min, and the melanin contents were 
observed at 360 nm with a micro plate reader. The effect of cell viability (protein 
contents) was evaluated by measuring at 595 nm. 
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Figure 2.25 Anti-melanin deposition activities of 10 at lower concentration against 
a-MSH and IBMX-induced melanogenesis, as well as protein contents in B16-F10 cell 
line. The assay was performed as the same procedure as those shown in Figure 2.24, 
except for final concentrations of samples (5, 10, 25, and 50 mM). 
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2.5 Tyrosinase inhibition activity of compounds 4 and 11 
To better understand anti-melanin deposition mechanism, the effects of 4 and 
11 on tyrosinase activities were investigated. Tyrosinase is the key enzyme catalyzing 
the hydrolation of tyrosine for the formation of L-DOPA and oxidation of L-DOPA for 
the DOPA quinone formation in the melanin biosynthesis (Figure 1.1).68 Tyrosinase 
inhibition activity was measured intermittently every 3 minutes for a total of 30 minute, 
in different concentrations (6.25, 12.5, 25, 50, 100, and 200 mM) (Figure 2.26). Kojic 
acid was used as a positive control. However, 4 and 11 did not inhibit tyrosinase 
activities.  
 
 
Figure 2.26 Effects of 4 and 11 on tyrosinase inhibition activity. The assay was 
performed on 96-well plate (final concentrations of 4 and 11 at 6.25, 12.5, 25, 50, 100, 
and 200 mM). The assay mixture containing 2.5 mM of L-DOPA as a substrate, 80 
units/mL of mushroom tyrosinase, and 4 or 11 at final concentration of 6.25, 12.5, 25, 
50, 100, or 200 mM was incubated at 37 °C for 10 min. The absorbance of DOPA 
quinone at 492 nm was measured intermittently for 30 min. Kojic acid (250 mM) was 
used as positive control. 
 
 
 
 47 
 
2.6 mRNA expression of compounds 4 and 11 
 Compounds 4 and 11 did not inhibit tyrosinase activities. Therefore, it is 
assumed that 4 and 11 showed the melanin deposition activity by inhibiting the cAMP 
pathway of melanogenesis. To further characterize the anti-melanin deposition activity, I 
examined the expression of mRNA using the specific primers for MITF, TYR, TRP-1, 
and TRP-2. The assay revealed that glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH) was used as the internal control. As a result, compound 4 down-regulated the 
Tyr mRNA expression. On the other hand, 11 showed down-regulation of the Mitf 
mRNA expression, together with those of Tyr, Trp-1, and Trp-2 (Figure 2.27). 
Considering these observations, anti-melanin deposition activity of 4 could be resulted 
from the Tyr mRNA expression, while that of 11 was caused from the down-regulation 
of the Mitf mRNA expression located upstream of Tyr, Trp-1, and Trp-2 in the cAMP 
pathway (Figure 1.2). 
 
Figure 2.27 Effects of 4 and 11 on mRNA expression. B16-F10 cells were seeded at 6.0 
´ 105 cells/dish on 6-cm dish, and mRNAs were induced by IBMX (100 mM) and 
a-MSH (0.25 mM) in the presence or absence of 100 mM of 4 and 11 for 24 h. Gapdh 
was used as an internal control. Numbers within parentheses indicate the number of 
PCR cycles. 
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2.7 Summary of chapter 2 
Four new lignoids, premnan A (1), premnan B (2), taungtangyiol C (3), and 
7,9- dihydroxydolichanthin B (4), together with premnan C (5) assumed to be an artifact, 
one natural new lignoid (3R,4S)-4-(1,3-benzodioxol-5-ylcarbonyl)-3-[(R)-1-(1,3- 
benzodioxol-5-yl)-1-hydroxymethyl]tetrahydro-2-furanone (6), and five known 
compounds (7-11) were isolated from the CHCl3 extract of the P. serratifolia wood. 
7,9-Dihydroxydolichanthin B (4) and (2a,3a)-olean-12-en-28-oic acid (11) displayed 
anti-melanin deposition activity against B16-F10 cell line with the IC50 values of 18.4 
and 11.2 mM, respectively. Furthermore, compounds 4 and 11 showed down-regulations 
of the Tyr and Mitf mRNA expressions, respectively. In contrast, 1−3, 5 and 7 showed 
melanogenesis enhancing activities. The anti-melanin deposition activity observed in 
the CHCl3 extract supported its effectiveness as natural cosmetics. Investigation of the 
chemical constituents and anti-melanin deposition activity of the P. serratifolia wood 
thus provided insight into the effectiveness of the P. serratifolia wood as a cosmetic 
agent. However, the present results also suggest that the cosmetic anti-melanin 
deposition efficacy of the P. serratifolia wood should be discussed with consideration of 
the melanogenesis enhancing activities of the chemical constituents in this plant. 
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Chapter 3  Constituents of the Jatropha multifida stems 
collected in Myanmar and their anti-melanin 
deposition activities 
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3.1 Introduction 
The genus, Jatropha, belongs to the Euphorbiaceae family and consists of 175 
species.69,70 Among them, J. multifida (Figures 3.1) is a shrub of 2-3 m in height and is 
grown as an ornamental plant in North Australia, South east Africa, Philippines, 
Srilanka, Indonesia, and India.71-73 In India and Africa, the whole parts of this plant 
likewise leaves, stem, bark, and roots have been used as ethno-medicines for a long time, 
to treat fever, pain, infection, wounds, ulcer, and various inflammatory skin 
conditions.74-76 Furthermore, several kinds of secondary metabolites such as 
acylfloroglucinols (multifidol and multifidol glucoside),77 diterpenoids (multifolone, 
(4E)-jatrogrossidenta-dione acetate, jatrophone, citlalitrione, 3b-acetoxy-12-metoxy-13 
-methyl-podocarpa-8,11,13-trien-7-one, (4E)-jatrogrossident adione, 15-epi-(4E)- 
jatrogrossidentadione,73 jatromulone A, 3b,12-dihydroxy-13-methylpodocarpane- 
8,10,13-trien,(2S,3R,5S,10R)-2,3-dihydroxy-15,16-dinor-ent-pimar-8,11,13-trien, (2S, 
3R,5S,10R)-2-acetoxy-3-hydroxy-15,16-dinor-ent-pimar-8,11,13-trien, gossweilone, 
jatrointeline A, jatrophodione A, heudelotinone78) and coumarino-lignan (cleomiscosin 
A)79 were isolated from this plant (Figure 3.2). Previous studied have indicated 
antibacterial activities against Bacillus subtilis and Staphylococus aureus,80 
anti-influenza virus activity,81 anti-inflammatory, antioxidant activities,82 cytotoxicity,83 
antifungal activity against Candida albicans,84 and antimalarial activities.85 However, 
there are no report for anti-melanin deposition activity and a few scientific reports have 
been described for the stems of J. multifida. 
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Figure 3.1 Stems of Jatropha multifida  
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Figure 3.2 Chemical structures of acylfloroglucinols, diterpenoids, and coumarino- 
lignan from J. multifida.  
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3.2 Extraction and isolation  
 The dried J. multifida stems (3.0 kg) were pulverized and extracted with CHCl3 
at room temperature four times. After filtration of the suspension, the resulting solution 
was evaporated under reduced pressure to yield a CHCl3 extract (11.0 g). The CHCl3 
extract (11.0 g) was chromatographed with silica gel column using a gradient system of 
increasing polarity with CHCl3 and EtOAc (10:1-0:10) to obtain five fractions (Fr. 1-Fr. 
5). These fractions were further separated by repeated column chromatography (Figure 
2.3), which furnished nine known compounds including two coumarins, scoparone 
(12)86 and scopoletin (13),87 and seven lignoids, salicifoliol (14),88 glaberide I (15),89 
pinoresinol (16), medioresinol (17), syringaresinol (18),90 matairesinol (19),87 and 
shonanin (20) 91 (Figures 3.3 and 3.4). The chemical structures of all compounds were 
determined by NMR spectroscopic data, and by comparison with reported data. All of 
these compounds have been isolated for the first time from this plant.   
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Figure 3.3 Extraction and isolation of compounds from CHCl3 extract of stems of J. 
multifida 
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Figure 3.4 Structures of compounds isolated from CHCl3 extract of J. multifida stems 
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3.3 Anti-melanin deposition activity of isolated compounds against a mouse 
melanoma cell line (B16-F10) 
The anti-melanin deposition activities of the isolated compounds 12-20 in a 
mouse melanoma cell line (B16-F10) were evaluated. Among the tested compounds, 
glaberide I (15) and shonanin (20) had anti-melanin deposition activities with IC50 
values of 49.9 and 37.5 mM, respectively, without any cytotoxicity (Figure 3.5). 
 
 
 
 
Figure 3.5 Anti-melanin deposition activities of 12-20 against a-MSH and 
IBMX-induced melanogenesis and protein contents in B16-F10 cell line. The assay was 
performed with the same procedures as those described in chapter 2. 
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3.4 Tyrosinase inhibition activity of compounds 15 and 20 
Since compounds 15 and 20 possessed the anti-melanin deposition activity, I 
examined the tyrosinase inhibition activity of 15 and 20. Tyrosinase inhibition activity 
was evaluated as same as chapter 2. However, 15 and 20 did not show the activity 
(Figure 3.6). 
 
 
 
Figure 3.6 Effects of 15 and 20 on tyrosinase inhibition activity. The assay was 
performed with the same procedures as those described in chapter 2. 
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3.5 mRNA expression of compounds 15 and 20 
In order to further clarify the inhibitory mechanism, I investigated the effects of 
15 and 20 on the mRNA expression of MITF, TYR, TRP-1, and TRP-2 and found that 
only 20 down-regulated the Tyr mRNA expression. However, 15 did not affect any 
mRNA expression (Figure 3.26). These results suggested that anti-melanin deposition 
activity of 20 could be resulted from the down-regulation of the Tyr mRNA expression, 
while anti-melanin deposition activity of 15 is caused from inhibition of other 
melanogenesis pathway. 
 
 
 
 
Figure 3.26 Effects of 15 and 20 on mRNA expression. The assay was performed with 
the same procedures as those described in chapter 2. 
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3.6 Summary of chapter 3 
Two coumarins, scoparone (12), scopoletin (13), and seven lignoids, salicifoliol 
(14), glaberide I (15), pinoresinol (16), medioresinol (17), syringaresinol (18), 
matairesinol (19), and shonanin (20) were isolated from the CHCl3 extract of the J. 
multifida stems. To the best of our knowledge, this is the first report of the isolation of 
the compounds 12-20 from J. multifida. Glaberide I (15) and shonanin (20) showed 
anti-melanin deposition activities with IC50 values of 49.9 and 37.5 mM, respectively. 
Further mechanistic investigation suggested that anti-melanin deposition activity of 20 
was caused by down-regulation of the Tyr mRNA expression. On the other hand, 15 did 
not show any effects on the expression of melanogenesis associated mRNA and 
tyrosinase inhibition activity, suggesting that the other inhibitory mechanism was 
occurred by 15 to decrease the melanin production. J. multifida was not used as 
traditional cosmetics. The results of this study may suggest that this plant is potentially 
used as a cosmetic ingredient. 
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Chapter 4   Constituents of the Myanmar marine sponge of 
Clathria prolifera and their anti-melanin and 
antifungal activities 
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4.1 Introduction 
Marine sponges from the genus Clathria are brightly orange or red colored 
encrustations with miniscule pores covered by finger-like branches or spikes.92,93 
Previous studies revealed that Clathria species harbor alkaloids, polyketide alkaloids, 
and steroids.94–98 Among the reported metabolites, clathsterol, a steroid from Clathria 
sp., reportedly possesses anti-HIV activity.96 The genus Clathria have provided some 
pharmacologically interesting compounds. Despite high possibility of this genus, the 
constituents of Clathria prolifera (Figure 4.1), which has been previously known as 
Microciona prolifera, have not been fully elucidated. Only previous chemical studies of 
C. prolifera revealed the presence of steroids. However, no biological activity has been 
reported.  
 
 
 
Figure 4.1 Clathria prolifera 
 
 
 
 
 
 
 62 
 
4.2 Extraction and isolation of active constituents  
Dried pieces of C. prolifera (79.5 g) were extracted in a MeOH-acetone 
mixture (2:1) with sonication (600 mL, 90 min´ 6) at room temperature, and the solvent 
was evaporated under reduced pressure to obtain the crude extract (11.9 g). The crude 
extract (11.9 g) was then suspended in water and successively partitioned with EtOAc 
(8 × 0.6 L), to obtain the EtOAc- (1.8 g) and water-soluble portions (9.6 g). The 
water-soluble portion (9.6 g) was fractionated on a DIAION HP-20 column, which was 
eluted stepwise with 2 L each of 100% H2O (Fr. 1), 50% MeOH (Fr. 2), and 100% 
MeOH (Fr. 3) to give three fractions. Fr. 2 (1.0 g) was further separated by sephadex 
LH-20 column chromatography and reverse-phase pTLC to furnish clathriroles A (21, 
1.0 mg) and B (22, 2.3 mg) (Figures 4.2 and 4.3). Two new compounds were elucidated 
based on 1D and 2D NMR, IR spectroscopy, HRESIMS, and comparisons of the 
reported literatures. Furthermore, the absolute configuration of 21 was determined by 
optical rotation and CD data analysis. 
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Figure 4.2 Extraction and isolation of compounds from C. prolifera. 
 
 
 
 
Figure 4.3 Structure of compounds isolated from C. prolifera. 
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4.3 Structure elucidation of new compounds 
4.3.1  Clathrirole A (21) 
Compound 21 was isolated as a white amorphous solid, with [a]D25 –27.7° (c 
0.1, CHCl3). The HRESIMS exhibited a 1:1 ion cluster at m/z 358.0398 [M+H]+ and 
360.0390, [M+2+H]+, indicating the presence of one bromine atom in 21. Its molecular 
formula was thus established as C13H16N3O4Br, by HRESIMS in conjugation with the 
NMR data. Its IR spectrum showed absoption bands at 3420, 1682, and 1624 cm−1, 
ascribable to hydroxy, carboxy, and imine functional groups, respectively. The 1H and 
13C NMR (Table 4.1, Figures 4.4 and 4.5) and HMQC spectroscopic data of 21 revealed 
signals for two heteroaromatic methine protons at δH 7.24 (H-2) and 6.79 (H-4), and an 
ester carbonyl carbon at δC 158.8 (C-6), two heteroaromatic methine carbons at δC 124.7 
(C-2) and 116.4 (C-4), an sp2 quaternary carbon at δC 121.9 (C-5), and a brominated 
heteroaromatic quaternary carbon at δC 96.1 (C-3), characteristic of those of a 
4-bromopyrrole-2-carboxylic acid ester.100,101 The remaining 1H NMR spectroscopic 
data revealed signals for two methines at δH 7.99 (H-13) and 3.67 (H-11), an 
oxymethylene at δH 4.39 (H-8a) and 4.24 (H-8b), an N-methyl group at δH 3.13 (H3-17), 
a methylene at δH 2.52 (H-10a) and 1.63 (H-10b), a tertiary methyl group at δH 1.38 
(H3-15), and a secondary amino proton at δH 12.51 (H-1). Analyses of the 13C NMR and 
HMQC spectra revealed the existence of a carbonyl carbon at δC 168.1 (C-16), an imine 
methine carbon at δC 151.9 (C-13), an oxymethylene carbon at δC 66.4 (C-8), a 
quaternary carbon at δC 56.3 (C-9), a methine carbon at δC 50.4 (C-11), a methylene 
carbon at δC 33.9 (C-10), an N-methyl carbon at δC 35.6 (C-17), and a tertiary methyl 
carbon at δC 20.7 (C-15). The presence of an N-methyl tetrahydropyrimidinium ring 
with the carboxylate moiety at C-11 was suggested by the 1H−1H COSY correlations of 
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H2-10/H-11, and the HMBC correlations from H2-8 to C-9/C-10, H2-10 to C-9/C-11, 
H3-17 to C-9/C-13, H-13 to C-9/C-11/C-17, H3-15 to C-8/C-9/C-10, and H-10b/H-11 to 
C-16 (Figure 4.6a). In addition, the connectivity of the 4-bromopyrrole-2-carboxylic 
acid and the N-methyl tetrahydropyrimidinium ring through C-8-O-C-6 was supported 
from the HMBC correlation of H2-8 to C-6. The 1H and 13C NMR spectroscopic data of 
21 were very similar to those of the known compound, N-methylmanzacidin C, isolated 
from the marine sponge Axinella brevistyla.102 The relative configuration of 21 was 
determined from the coupling constants and the NOESY data (Figure 4.6b). The 
axial/pseudo-axial relationship between H-10a and H-11 (5.2 Hz) and the 
equatorial/pseudo-equatorial relationship between H-10a and the carboxylate moiety at 
C-11 were confirm from the coupling constants between H-10b and H-11 (12.0 Hz). The 
NOESY correlations of H-10b/H-11 and of H-10a/H3-15, as well as the lack of a 
NOESY correlation of H-11/H3-15, suggested that the C-15 methyl group is equatorially 
oriented and adopts a b-configuration with that of the carboxylate moiety at C-16, while 
the methylene group at C-8 was assumed to adopt the a-configuration. 
The previously reported steroselective total synthesis of manzacidin C 
unambiguously confirmed its 9S,11S configuration.103 Furthermore, absolute 
configurations of N-methylmanzacidin C were assigned as 9S and 11S by comparison of 
its optical rotation ([a]D23 +36.4°) with that of the synthesized manzacidin C ([a]D22 
+37°).102 However, 21 exhibited a negative optical rotation value. Therefore, both C-9 
and C-11 of 21 were assumed to be R configurations. Furthermore, this assignment was 
also supported by comparison of the experimental and calculated ECD spectra analysis 
(Figure 4.7), Thus, the structure of 21 was assigned as an enantiomer of 
N-methylmanzacidin C, and named clathrirole A. 
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Figure 4.4 1H NMR spectrum (500 MHz) of 21 in CD3OD 
 
 
 
Figure 4.5 13C NMR spectrum (125 MHz) of 21 in CD3OD 
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Figure 4.6 1H-1H COSY correlations (bold lines) and key HMBC correlations (arrows) 
(a) and key NOESY correlations (dashed arrows) of 21 (b) 
 
 
 
 
Figure 4.7 Experimental and calculated ECD spectra of 21 
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Table 4.1 1H and 13C NMR data for clathrirole A (21). 
No. 21a  21b 
 dC  dH (mult., J in Hz)  dC  dH (mult., J in Hz) 
1   12.51(s)     
2 124.7  7.24 (d, 1.2)  125.8  7.04 (br, s) 
3 96.1    98.4   
4 116.4  6.79 (d, 1.7)  118.5  6.86 (br, s) 
5 121.9    123.3   
6 158.8    160.6   
8 66.4  4.39 (d, 11.6)  67.3  4.59 (d, 11.9) 
   4.24 (d, 11.6)    4.31 (d, 11.9) 
9 56.3    58.4   
10 33.9  2.52c  35.2  2.65 (dd, 5.2, 14.3) 
   1.63 (dd, 12.0, 14.3)    1.96 (dd, 10.9, 14.3) 
11 50.4  3.67 (dd, 5.2, 12.0)  52.4  4.15 (dd, 5.2, 10.9) 
13 151.9  7.99 (s)  154.1  7.98 (s) 
15 20.7  1.38 (3H, s)  21.6  1.49 (3H, s) 
16 168.1    174.2   
17 35.6  3.13 (3H, s)  37.1  3.25 (3H, s)  
a 1H NMR at 500 MHz, 13C NMR at 125 MHz, measured in DMSO-d6 
b 1H NMR at 500 MHz, 13C NMR at 125 MHz, measured in CD3OD 
c Overlapping resonance with solvent peak 
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4.3.2  Clathrirole B (22) 
Compound 22 was obtained as a white amorphous solid with [α]D25 –29.3° (c 
0.1, CHCl3), and was revealed to have the molecular formula C13H17N3O4 by HRESIMS 
(m/z 280.1292). The IR spectrum displayed the presence of the hydroxy (3424 cm-1), 
carboxy (1683 cm-1), and imine (1616 cm-1) functional groups. The 1H and 13C NMR 
data of 22 (Table 4.2, Figures 4.8 and 4.9) were quite similar to those of 21 recorded in 
CD3OD (Table 4.1, Figures 4.4 and 4.5). The significant difference between 22 and 21 
was the presence of a heteroaromatic methine proton on the pyrrole ring at C-3 in 22, 
instead of bromine in 21. This was verified from the 1H−1H COSY correlations of 
H-2/H-3 and H-3/H-4, and the HMBC correlations from H-2 to C-3/C-4/C-5, from H-3 
to C-4/C-5, and from H-4 to C-2/C-3/C-5 (Figure 4.10a). Furthermore, the NOESY 
experiment suggested that 22 has the same relative configuration as that of 21 (Figure 
4.10b). The relative configuration of 22 was also confirmed by comparisons of the 1H 
and 13C NMR data with those of the structurally most similar known compound, 
manzacidin D, isolated from the marine sponge Astrosclera willeyana.104 The significant 
differences between 22 and manzacidin D were sets of proton and carbon signals at 
C-10 (δH 2.66 and 1.95 and δC 35.3 in 22; δH 2.37 and 2.30 and δC 33.5 in manzacidin 
D) and at C-11 (δH 4.19 and δC 52.4 in 22; δH 4.11 and δC 51.4 in manzacidin D), as well 
as the carbon signal at C-16 (δC 174.2 in 22; δC 181.4 in manzacidin D), suggesting that 
the relative configuration of the carboxylate moiety at C-11 in 22 was the b-orientation. 
Furthermore, the optical rotation of 22 showed negative as same as 21, suggesting that 
absolute configurations of C-9 and C-11 of 22 were assumed to adopt R. Hence, the 
structure of 22 was determined as a diastereomer of manzacidin D at C-11, and was 
given the trivial name clathrirole B. 
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Figure 4.8 1H NMR spectrum (500 MHz) of 22 in CD3OD 
 
 
 
 
 
Figure 4.9 13C NMR spectrum (125 MHz) of 22 in CD3OD 
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Figure 4.10 1H-1H COSY correlations (bold lines) and key HMBC correlations (arrows) 
(a) and key NOESY correlations (dashed arrows) of 22 (b) 
 
 
Table 4.2  1H and 13C NMR data for clathrirole B (22). 
 
a 1H NMR at 900 MHz, 13C NMR at 225 MHz, measured in CD3OD 
 
No. 22a 
 dC  dH (mult., J in Hz) 
2 125.7  7.03 (dd, 1.4, 2.2) 
3 111.1  6.22 (dd, 2.2, 3.6) 
4 117.3  6.88 (dd, 1.4, 3.6) 
5 122.4   
6 161.4   
8 66.9  4.62 (d, 11.7) 
   4.29 (d, 11.7) 
9 58.5   
10 35.3  2.66 (dd, 5.4, 14.4) 
   1.95 (dd, 10.8, 14.4) 
11 52.4  4.19 (dd, 5.4, 10.8) 
13 153.9  7.98 (s) 
15 21.5  1.49 (3H, s) 
16 174.2   
17 36.9  3.25 (3H, s) 
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4.4 Anti-melanin deposition activities of clathrirole A (21) and clathrirole B (22) 
 I evaluated the effect of two new compounds (21 and 22) on anti-melanin 
deposition activities in a mouse melanoma cell line (B16-F10). However, both 
compounds did not show any anti-melanin deposition activites (Figure 4.7). 
 
 
Figure 4.7 Anti-melanin deposition activities of compounds 21 and 22 against a-MSH 
and IBMX-induced melanogenesis, as well as protein contents in B16-F10 cell line 
This assay procedure was performed as same as those of chapter 2. 
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4.5 Antifungal activities of compounds clathrirole A (21) and clathrirole B (22) 
N-methylmanzacidin C, the enantiomer of 21, reportedly possessed antifungal 
activity against Saccharamyces cerevisiae strain.102 Based on this reason, antifungal 
activities of 21 and 22 were assessed with S. cerevisiae. Cyclohexamide was used as 
positive control. However, compounds 21 and 22 did not show any activity against S. 
cerevisiae at a concentration of 200 mM (Table 4.4). These observations would suggest 
that the absolute configurations (C-9 and C-11) are related in the antifungal activity of 
N-methylmanzacidin C.99 
 
 
Table. 4.4 Antifungal activities of compounds 21 and 22 against Saccharamyces 
cerevisiae strain 
Compounds Concentration (µM) 
Chlathrirole A (21) > 200 
Chlathrirole B (22) > 200 
Cyclohexamide a < 3.16 
a Positive control 
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4.6 Summary of chapter 4 
Two new pyrrolo-2-aminoimidazoles, clathriroles A (21) and B (22), were 
isolated from the 50% MeOH fraction from the MeOH-acetone mixture (2:1) crude 
extract of C. prolifera. Compound 21 was an enantiomer of N-methylmanzacidin C with 
antifungal activity, whereas 22 was a diastereomer of manzacidin D. However, 
compounds 21 and 22 did not show anti-melanin deposition activity. Furthermore, 
unlike N-methylmanzacidin C, 21 and 22 did not show antifungal activity against S. 
cerevisiae. Thus, these observations may suggest that the absolute configurations play 
an important role for exhibiting the antifungal activity in this type of compounds.  
To the best of our knowledge, pyrrolo-2-aminoimidazole compounds were 
isolated for the first time from C. prolifera. Furthermore, this is the first report for the 
chemical constituents from Myanmar marine sponges. 
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Conclusions 
In this study, the chemical constituents of two plants, P. serratifolia and J. 
multifida, and one marine sponge C. prolifera collected in Myanmar were analyzed for 
their anti-melanin deposition activity against a-MSH and IBMX induced B16-F10. The 
chemical investigation of the plants’ active extracts led to isolation of 20 compounds 
including five new lignoids 1−5 and 15 known compounds 6−20. Compounds 4, 11, 15, 
and 20 exhibited significant anti-melanin deposition activities with the IC50 values of 
18.4, 11.2, 49.9, and 37.5 mM, respectively. Furthermore, 4 and 20 inhibited the 
expression of Tyr mRNA, while 11 inhibited the expression of Mitf mRNA. In contrast, 
1−3, 5, and 7 showed melanogenesis enhancing activities. In addition, two new 
pyrrolo-2-aminoimidazoles 21 and 22 were isolated from C. prolifera. However, 21 and 
22 did not show anti-melanin deposition activities. Taken together, our present study 
suggested that the less studied Myanmar natural resources are potential as new sources 
of secondary metabolites for anti-melanin deposition agents. 
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Experimental 
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I. General experimental procedures 
 
General methods 
Optical rotations were recorded on a Jasco P2100 polarimeter. UV spectra were 
measured on a Shimadzu UV-160A spectrophotometer. IR spectra were recorded with 
KBr pellets on a Jasco FT/IR-460 Plus spectrometer. CD spectra were obtained using a 
JASCO-J-805 spectropolarimeter. NMR spectra were recorded at 500 MHz (1H NMR) 
and 125 MHz (13C NMR) on a JEOL 500II spectrometer on a JEOL ECX-500 
spectrometer, or at 600 MHz (1H NMR) and 150 MHz (13C NMR) on a Bruker 
AVANCE III HD 600 spectrometer with a QCI-F CryoProbe or BrukerAvance III 900 
MHz NMR spectrometer, 900 MHz (1H NMR) and 225 MHz (13C NMR) at RIKEN 
Yokohama. Chemical shift values are expressed in δ (ppm) downfield from TMS as an 
internal standard. The high-resolution mass spectra were recorded on a JEOL MStation 
JMS-700 spectrometer. Medium Pressure Liquid Chromatography (MPLC) was 
performed using Büchi Sepacore system (Büchi Labortechnik AG, Flawil, Switzerland). 
HPLC was mainly performed with an Agilent Technologies 1260 quat pump with a 
JEOL detector. For HPLC column chromatography, COSMOSIL 5C18-AR-II (10 ´ 250 
mm) was used. Open column chromatography was performed with normal-phase silica 
gel (silica gel 60N, spherical, neutral, 40-50 mm, Kanto Chemical Co., Inc., Japan) and 
Cosmosil 75C18-OPN (Nacalai Tesque Inc., Kyoto, Japan). Analytical and preparative 
TLCs were performed on pre-coated silica gel 60F254 plates and RP-18F254 plates 
(0.25-mm thick for analytical TLC and 0.50-mm thick for preparative TLC (pTLC), 
Merck KGaA, Darmstadt, Germany). 
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Extraction and preparation of test solution 
Five natural products were dried and used for making powder, which was 
macerated with CHCl3 and MeOH to obtain CHCl3 and MeOH crude extracts. After 
solvent was evaporated under reduced pressure, the crude extract was dissolved in 
DMSO and used for the anti-melanin deposition assay. 
 
Cell culture and Anti-melanin Deposition Assay  
B16-F10 mouse melanoma cells (RCB1158) were grown in Dulbecco's 
Modified Eagle Medium (DMEM), supplemented with 10% heat incubated FBS 
(Sigma-Aldrich) and 1% penicillin (10,000 U/mL)-streptomycin (10 mg/L) (Gibco). 
The B16-F10 cells were seeded in a 24-well plate at 5.0 ´ 104 cells/well and cultured in 
500 mL of medium (DMEM at 37 °C, under a 5% CO2 and 95% air atmosphere). After 
24 h of culture, 500 mL of medium containing different doses of the tested samples 
(final conc. 10, 50, and 100 mM), a-MSH (final conc. 0.25 mM), and IBMX (final conc. 
100 mM) was added to each well. After 48 h incubation, 500 mL of the medium was 
discarded, and 500 mL of medium containing different doses of the tested samples, 
a-MSH, and IBMX was added to each of the wells at the concentrations of the same as 
described above and further incubated for 48 h. The cells were then washed twice with 
PBS (200 mL) and lysed by incubation in 1 N NaOH (150 mL) at 95 °C for 15 min, and 
then the absorbance at 360 nm was measured with a microplate reader (SH-1200, 
Corona). The effect of the samples on the cell proliferation and viability was evaluated 
by measuring the absorbance of the total protein content at 595 nm with a Bio-Rad 
Protein Assay. Arbutin (Sigma) was used as positive controls for the anti-melanin 
deposition and melanogenesis enhancing activities, respectively, in the present study.  
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Tyrosinase inhibition activity  
Tyrosinase assay was performed with 2.5 mM of L-DOPA as substrate and 80 
units/mL of mushroom tyrosinase on 96-well plate (final concentration of 4, 11, 15 and 
20 at 6.25, 12.5, 25, 50, 100, and 200 mM), and the assay mixture was allowed to 
proceed at 37 °C. The absorbance of DOPA quinone was measured at 492 nm 
intermittently for 30 min. Kojic acid (Tokyo Chemical Industry, Japan) was used as a 
positive control. 
 
Reverse transcription-PCR  
B16-F10 cells were seeded 6.0 ´ 105 cells/dish on 6-cm dish, and induced 
exposure to IBMX (100 mM) and a-MSH (0.25 mM) with/without 4, 11, 15 and 20 for 
24 h. After the treatment, cells were washed with PBS and lysed in 500 mL of TRIsure 
reagent (Nippon Genetics, Tokyo). Reverse transcriptions were performed using the 
ReverTra Ace kit (Toyobo, Osaka). Polymerase chain reactions were carried out using 
the PCR kit from GeneRed. 2mg/mL of 1st strand cDNA was used for each PCR reaction 
with the synthesized forward and reverse primers listed below: GAPDH (forward: 
5¢-TCATCATCTCCGCCCCTTC-3¢, reverse: 5¢-TGCCTGCTTCACCACCTTCT-3¢), 
MITF (forward: 5¢-GTGCAGACCCACCTGGAAAAC-3¢, reverse: 5¢-AGTTAAGAGT 
GAGCATAGCCATAG-3¢), TYR (forward: 5¢-GATCAGAAGAGTATAATAGCCAT-3¢, 
reverse: 5¢-CAATATAAGGGCTGTAAAAGCCT-3¢), TRP-1 (5¢-GATATGGCGAAGC 
GCACAAC-3¢,reverse: 5¢-GTGCCATGTGAGAAAAGCGG-3¢), and TRP-2 (5¢-CCAA 
CTGCAGCGTGTATGACT-3¢, reverse: 5¢-GTCTGTGCACACGTCACACT-3¢). All 
PCR products were separated by 2% agarose gel electrophoresis and visualized by 
ethidium bromide staining.  
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II. Experimental detail of chapter 2 
 
Plant material  
The dried powder of the P. serratifolia (4.8 kg) wood was collected from Myeik 
Township, Tanintharyi Region, Myanmar, in February 2018, and identified by an 
authorized botanist in the Department of Botany, University of Yangon. A voucher 
specimen (TMPW 27829) was deposited at the Museum of Materia Medica, Research 
Center for Ethnomedicines, Institute of Natural Medicine, University of Toyama, Japan. 
 
DFT/TDDFT calculations 
To generate the conformers subjected to the DFT/TDDFT calculations, Merck 
Molecular Force Field (MMFF) calculations were performed by using the Spartan ’14 
software package (Wavefunction Inc., Irvine, CA, USA), and 21, 68, and 12 low-energy 
conformers were generated from 2, 3, and 5, respectively.  
All DFT/TDDFT calculations were conducted using the Gaussian 09 
software.105 Initially, each low-energy conformer obtained by MMFF calculations was 
subjected to geometry optimization by the DFT method at the B3LYP/6-31G(d) level, 
with the Polarizable Continuum Model (PCM) in MeOH. Subsequently, to estimate the 
thermal free energy (ΔG) and check for the presence of imaginary frequencies, each 
optimized conformer was subjected to a frequency calculation at the B3LYP/6-31G(d) 
level with the PCM in MeOH. Based on the estimated thermal energy, the abundance 
ratio of each conformer was determined by the Boltzmann distribution, and finally, we 
selected 3 conformers from 2 (in total, occupying approximately 90%), 6 conformers 
from 3 (in total, occupying apporoximately 95%), and 5 conformers from 5 (in total, 
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occupying approximately 90%) for ECD calculations. Calculations of the ECD spectra 
of all conformers were performed by using the TDDFT method at the B3LYP/6-31G(d) 
level with PCM in MeOH, and the weighted-average spectra were compared with the 
experimental ECD spectra recorded in MeOH.  
 
Extraction and isolation procedure 
The dried powdered wood of P. serratifolia (4.8 kg) was sonicated in CHCl3 (8 
L, 90 min, ´4) at room temperature and the solvent was removed using an evaporator 
under reduced pressure to obtain the CHCl3 extract (31.5 g). The CHCl3 extract (31.5 g) 
was subjected to silica gel column chromatography using n-hexane-EtOAc (10:1, 8:2, 
7:3, 5:5, 3:7, 2:8, 0:10, v/v) as a solvent system to give ten fractions (Fr. 1-10).  
Fraction 7 (1.9 g) was rechromatographed on silica gel column chromatography 
with n-hexane-EtOAc (10:1, 7:3, 5:5, 3:7, 0:10, v/v) to obtain four subfractions (Fr. 
7-1-7-4). A portion of subfraction 7-4 was further chromatographed on Cosmosil 
75C18-OPN resin with a MeCN-MeOH-acetone-H2O solvent system (1:1:1:2) to 
afford oleanonic acid (10, 4.2 mg). 
Fraction 8 (1.0 g) was subjected into silica gel column, which was eluted with 
n-hexane-EtOAc (10:1, 7:3, 5:5, 3:7, 0:10, v/v) to afford four subfractions (Fr. 8-1-8-4). 
Subfraction 8-4 was further purified by reversed-phase HPLC, eluted with an 80% 
MeOH isocratic solvent system and monitored at the wavelength of 254 nm, to afford 
(-)-aptosimon (7, 2.0 mL/min, tR = 9.2 min, 3.4 mg) and (-)-diasesamin-di-g-lactone (8, 
2.0 mL/min, tR = 11.0 min, 17.1 mg).  
Fraction 9 (1.5 g) was rechromatographed on silica gel column with 
n-hexane-EtOAc (10:1 to 0:10, v/v) to give five subfractions (Fr. 9-1-9-5). (2a, 
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3a)-Dihydroxyolean-12-en-28-oic acid (11, 3.3 mg) was obtained from the further 
purification of subfraction 9-2 on Cosmosil 75C18-OPN resin with MeOH-H2O (4:1). 
Fraction 10 (8.1 g) was subjected to silica gel column, using an 
n-hexane-CH2Cl2-EtOAc (2:2:1, v/v) solvent system, to give seven subfractions (Fr. 
10-1-10-7). Subfraction 10-3 was subjected to chromatography on Cosmosil 
75C18-OPN with MeOH-H2O (4:1) to yield three subfractions (Fr. 10-3-1-10-3-3). 
Subfraction 10-3-2 was then purified by normal-phase pTLC, using n-hexane- 
CH2Cl2-EtOAc (2:2:1, v/v), to isolate premnan B (2, 1.6 mg). Subfraction 10-4 was 
purified by reversed phase open column chromatography eluted with 
MeCN-MeOH-H2O (2:2:1, v/v) to give four subfractions (10-4-1-10-4-4), and 
subfraction 10-4-2 was further purified by reverse-phase pTLC with MeOH–H2O (4:1, 
v/v), to yield taungtangyiol C (3, 3.0 mg), 7,9-dihidroxydolichanthin B (4, 8.1 mg), and 
premnan C (5, 2.1 mg). (3R,4S)-4-(1,3-Benzodioxol-5-ylcarbonyl)-3-[(R)-1- 
(1,3-benzodioxol-5-yl)-1-hydroxymethyl]tetrahydro-2-furanone (6, 1.6 mg) and 
(+)-epi-sesaminone (9, 4.0 mg) were obtained from the purification of a portion of 
subfraction 10-5-1 by reverse-phase pTLC with MeOH–H2O (4:1, v/v). Premnan A (1, 
1.7 mg) was obtained by reverse-phase pTLC with MeOH–H2O (4:1, v/v) from 
subfraction 10-5-2. 
 
Premnan A (1): pale yellow, amorphous solid; [a]25D +83.2° (c 0.1, MeOH); 
UV (MeOH) lmax (log e) 247 (3.95), 260 (3.99), 360 (3.80) nm; IR (KBr) nmax 3463, 
2923, 2854, 2369, 2343, 2071, 1656, 1640, 1592, 1503, 1485, 1442, 1370, 1286, 1231, 
1167, 1138, 1097, 1039, 931 cm-1; CD (MeOH) (De) 215 (-13.35), 234 (+7.61), 258 
(-10.40), 317 (-4.02), 348 (+6.77); 1H and 13C NMR data, see Table 2.1; HRESIMS m/z 
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375.0869 [M+Na]+ (calcd. for C20H16O6Na: 375.0839). 
 
Premnan B (2): white, amorphous solid; [a]25D +1.6° (c 0.1, MeOH); UV 
(MeOH) lmax (log e) 245 (3.70), 288 (3.78) nm; IR (KBr) nmax 3470, 2964, 2920, 2853, 
2371, 1638, 1498, 1446, 1408, 1261, 1097, 1033, 933, 865, 803 cm-1; CD (MeOH) (De) 
205 (-5.72), 216 (+6.46), 234 (+12.14), 258 (+4.94), 269 (+5.18); 1H and 13C NMR data, 
see Tables 2.2; HRESIMS m/z 409.0868 [M+Na]+ (calcd. for C20H18O8Na: 409.0894). 
 
Taungtangyiol C (3): white, amorphous solid; [a]25D -55.5° (c 0.1, MeOH); 
UV (MeOH) lmax (log e) 247 (4.07), 285 (4.05) nm; IR (KBr) nmax 3436, 2964, 2931, 
2359, 2328, 1713, 1450, 1377, 1241 cm-1; CD (MeOH) (De) 203 (-4.18), 227 (+4.16), 
269 (-0.74), 283 (-0.50); 1H and 13C NMR data, see Tables 2.3; HRESIMS m/z 
395.1101 [M+Na]+ (calcd. for C20H20O7Na: 395.1101).  
 
7,9-Dihydroxydolichanthin B (4): white amorphous solid; [a]D25 +8.7° (c 0.1, 
MeOH); UV lmax (MeOH) nm (log e): 245 (3.67), 288 (3.82) nm; IR (KBr) nmax 3405, 
2896, 2361, 2255, 2066, 1849, 1646, 1490, 1443, 1377, 1245, 1098, 1030, 1000, 929, 
816 cm-1; 1H and 13C NMR: see Table 2.4; HRESIMS m/z [M+Na]+ (calcd. for 
C20H20O8Na: 411.1050; found: 411.1049). 
 
Premnan C (5): pale yellow, amorphous solid; [a]25D +4.7° (c 0.1, MeOH); 
UV (MeOH) lmax (log e) 245 (3.67), 285 (3.74) nm; IR (KBr) nmax 3458, 2924, 2860, 
2373, 2342, 1634, 1491, 1444, 1382, 1249, 1219, 1165, 1106, 1073, 1038, 1038, 934, 
802 cm-1; CD (MeOH); (De) 195 (-5.75), 199 (+10.11), 204 (-13.47), 210 (-15.21), 
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225 (+10.39), 232 (+8.22); 1H and 13C NMR data, see Table 2.5; HRESIMS m/z 
451.1368 [M+Na]+ (calcd. for C23H24O8Na: 451.1363). 
 
(3R,4S)-4-(1,3-Benzodioxol-5-ylcarbonyl)-3-[(R)-1-(1,3-benzodioxol-5-yl)-1-
hydroxy methyl]tetrahydro-2-furanone (6): white amorphous solid; 1H NMR (500 
MHz, CDCl3) d: 3.56 (dd, J = 8.0, 3.4 Hz, 1H, H-1), 4.56 (dd, J = 8.6, 9.2 Hz, 1H, H-4a), 
4.18 (dd, J = 8.0, 8.6 Hz, 1H, H-4b), 4.43 (dd, J = 8.0, 16.0 Hz, 1H, H-5), 6.74 (m, 1H, 
H-6), 7.10 (d, J = 1.7 Hz,  1H, H-2¢), 6.74 (m, 1H, H-5¢), 7.24 (dd, J = 1.7, 8.0 Hz, 1H, 
H-6¢), 6.04 (s, 2H, H-7¢), 6.78 (d, J = 8.0 Hz, 1H, H-2²), 6.74 (m, 1H, H-5²), 6.62 (d, J = 
8.6 Hz, 1H, H-6²), 5.59 (brs, 1H, H-7²a), 5.85 (brs, 1H, H-7²b); 13C NMR data (125 
MHz, CDCl3) d: 52.5 (C-1), 176.3 (C-2), 69.1 (C-4), 41.9 (C-5), 106.0 (C-6), 195.0 
(C-7), 130.1 (C-1¢), 107.9 (C-2¢), 148.3 (C-3¢), 152.4 (C-4¢), 106.0 (C-5¢), 124.8 (C-6¢), 
102.1 (C-7¢), 134.3 (C-1²), 107.9 (C-2²), 147.8 (C-3²), 147.1 (C-4²), 108.2 (C-5²), 
118.6 (C-6²), 101.1 (C-7²); The above data are identical with those of 
(3R,4S)-4-(1,3-benzodioxol-5-ylcarbonyl)-3-[(R)-1-(1,3-benzodioxol-5-yl)-1-hydroxym
ethyl]tetrahydro-2-furanone in the literature.57  
 
(-)-Aptosimon (7): white amorphous solid; 1H NMR (500 MHz, CDCl3) d: 
3.21 (m, 1H, H-1), 5.30 (d, J = 4.0 Hz, 1H, H-2), 3.43 (dd, J = 9.2, 3.5 Hz, 1H, H-5), 
5.32 (d, J = 4.0 Hz, 1H, H-6), 4.32 (dd, J = 9.2, 6.9 Hz, 1H, H-8a), 4.02 (dd, J = 9.2, 4.6 
Hz, 1H, H-8b), 6.82 (brs, 1H, H-2¢), 6.76 (m, 1H, H-5¢), 6.80 (m, 1H, H-6¢), 5.96 (s, 2H, 
H-7¢), 6.87 (brs, 1H, H-2²), 6.77 (m, 1H, H-5²), 6.85 (m, 1H, H-6²), 5.99 (s, 2H, H-7²); 
13C NMR data (125 MHz, CDCl3) d: 50.5 (C-1), 83.3 (C-2), 176.6 (C-4), 53.3 (C-5), 
84.4 (C-6), 72.6 (C-8), 133.0 (C-1¢), 108.3 (C-2¢), 148.0 (C-3¢), 147.2 (C-4¢, C-4²), 
